GlassScriptPhysician profile
Thomas P Kole
NPI 1598064545
$8,394.55
in general payments reported to CMS, 2019-2025
14 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2021: $1,543 · 2022: $1,766 · 2023: $3,035 · 2024: $931 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,292 · Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,292.13 |
| Food and Beverage | $2,064.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $4,677.74 | 2019-2025 | Image Guided Surgical Device, Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Brainlab, INC. |
| Novocure INC. | $2,231.52 | 2019-2024 | Optune, Optune Lua (Novottf-200t) |
| Boston Scientific Corporation | $413.65 | 2024-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Zap Surgical Systems, INC. | $315.88 | 2024 | Zap-X Treatment Delivery Software, Zap-X Mv Imager, Zap-X Treatment Planning Software |
| Elekta, INC. | $315.73 | 2021-2024 | Leksell Gamma Knife Icon |
| Accuray Incorporated | $134.08 | 2019 | |
| Progenics Pharmaceuticals, INC. | $107.63 | 2023 | Pylarify |
| Varian Medical Systems, INC. | $92.60 | 2019 | |
| Sumitomo Pharma America, INC. | $27.53 | 2023 | Orgovyx |
| Myovant Sciences INC. | $19.09 | 2022 | |
| Palette Life Sciences, INC. | $17.45 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $14.93 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.22 | 2024 | Varian Treatment |
| Fortovia Therapeutics, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.